Author： PharmD Jenna L. Yoder
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.28, Iss.7, 2008-01, pp. : 461-462
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Access to resources
Recommend
Sensitivity Analysis in Cost-Effectiveness Studies: From Guidelines to Practice
By Jain Rahul
PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. :
Estimating `Costs' for Cost-Effectiveness Analysis
By Miners Alec
PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. :
Subgroups and Heterogeneity in Cost-Effectiveness Analysis
PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. :
Exploring Uncertainty in Cost-Effectiveness Analysis
By Claxton Karl
PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. :